Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Pediatrics (Suppl Consilium Medicum), Consilium Medicum, , No. 1 ( 2020), p. 16-19
    Abstract: Представлен обзор литературы, посвященный основным особенностям новой коронавирусной инфекции у детей. Отмечено, что до настоящего времени нет убедительных данных в пользу вертикального инфицирования, в то время как показана возможность горизонтальной передачи ин-фекции от матери ее новорожденному ребенку. Приводятся основные положения согласованных рекомендаций международных и национальных профессиональных медицинских сообществ по тактике ведения новорожденных детей от матерей с COVID-19 (Coronavirus disease 2019). Пока-зано, что в структуре пациентов с тяжелым течением COVID-19 на долю детей приходится не более 5%. Установлено, что у детей новая корона-вирусная инфекция в подавляющем большинстве случаев протекает бессимптомно или в легкой форме. Представлены основные гипотезы более легкого течения COVID-19 у педиатрических пациентов. При этом особо подчеркивается, что дети с бессимптомным и легким течением заболева-ния составляют основной трансмиссивный потенциал для продолжения пандемии. Ключевые слова: дети, новая коронавирусная инфекция, новорожденные дети, COVID-19. Для цитирования: Заплатников А.Л., Горев В.В., Дмитриев А.В. и др. Педиатрические вопросы о новой коронавирусной инфекции – есть ли на них сегодня ответы? Педиатрия. Consilium Medicum. 2020; 1: 16–19. DOI: 10.26442/26586630.2020.1.200122
    Type of Medium: Online Resource
    ISSN: 2658-6630 , 2658-6622
    Uniform Title: Педиатрические вопросы о новой коронавирусной инфекции – есть ли на них сегодня ответы?
    Language: Unknown
    Publisher: Consilium Medicum
    Publication Date: 2020
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: Frontiers in Immunology, Frontiers Media SA, Vol. 14 ( 2023-8-1)
    Abstract: To protect young individuals against SARS-CoV-2 infection, we conducted an open-label, prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the immunogenicity and safety of the prime-boost “Sputnik V” vaccine administered at 1/10 and 1/5 doses to adolescents aged 12–17 years. The study began with the vaccination of the older cohort (15-to-17-year-old participants) with the lower (1/10) dose of vaccine and then expanded to the whole group (12-to-17-year-old participants). Next, 1/5 dose was used according to the same scheme. Both doses were well tolerated by all age groups. No serious or severe adverse events were detected. Most of the solicited adverse reactions were mild. No significant differences in total frequencies of adverse events were registered between low and high doses in age-pooled groups (69.6% versus 66.7%). In contrast, the 1/5 dose induced significantly higher humoral and T cell-mediated immune responses than the 1/10 dose. The 1/5 vaccine dose elicited higher antigen-binding (both S and RBD-specific) as well as virus-neutralising antibody titres at the maximum of response (day 42), also resulting in a statistically significant difference at a distanced timepoint (day 180) compared to the 1/10 vaccine dose. Higher dose resulted in increased cross-neutralization of Delta and Omicron variants.; Clinical Trial Registration ClinicalTrials.gov , NCT04954092, LP-007632.
    Type of Medium: Online Resource
    ISSN: 1664-3224
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2023
    detail.hit.zdb_id: 2606827-8
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: Pediatrics. Consilium Medicum, Consilium Medicum, , No. 2 ( 2022-07-30), p. 166-173
    Abstract: Aim. To establish the etiological structure and to present clinical and laboratory and instrumental characteristics of bronchiectasis (BE) not associated with cystic fibrosis (CF) in children. Materials and methods. Sixty-seven hospitalised patients with BЕ not related to CF were followed up between 2017 and 2022. Examination methods: clinical-anamnestic method, general clinical laboratory investigations, investigation of allergological and immune status, phagocytosis system, determination of concentration of specific IgE and IgG to fungi of genus Aspergillus, sweat test, radiological examination and computed tomography (CT) of chest organs, bronchoscopy, Bacteriological examination of sputum and/or tracheobronchial aspirates, nasal and/or bronchial ciliary motility, esophagogastroduodenoscopy, 24-hour pH-metry, intra-esophageal combined impedance-pH-metry, genetic study, lung biopsy. Results. Etiologic factors of BЕ not associated with CF in children were severe pneumonia (22%), primary ciliary dyskinesia (22%), bronchial asthma (13%), Williams-Campbell syndrome (7%), bronchial foreign bodies (7%), gastroesophageal reflux disease (6%), Bronchopulmonary dysplasia (6%), postinfectious bronchiolitis obliterans (5%), allergic bronchopulmonary aspergillosis (3%), chronic granulomatous disease (3%), AIDS (1%), prolonged bacterial bronchitis (1%), brain-lung-thyroid syndrome (1%). The clinical picture is characterized by cough (91%), shortness of breath (67%), fever during exacerbation (48%), chest pain (24%), exercise intolerance (55%), drumstick symptom (9%), moist (76%) and dry wheezing (37%). CT-semiotics of BЕ not associated with CF is characterized by localization in one (58%) or several (42%) lobes; traction (42%), non-traction (49%) B and their combination (9%); increased broncho-arterial ratio 0.9; thickening of bronchial wall; "mosaic perfusion"/"air-trap" symptom (9%); more frequent involvement of lower lungs (64%). The main infectious agents in BЕ not associated with CF were Haemophilus influenzae, Pseudomonas aeruginosa, Staphylococcus aureus. Conclusion. On the basis of a multicentre study, the etiological structure, clinical and laboratory and CT-characteristics of non-CF ВE in children were established.
    Type of Medium: Online Resource
    ISSN: 2658-6622 , 2658-6630
    Language: Unknown
    Publisher: Consilium Medicum
    Publication Date: 2022
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages